Asthma patient hospitalization risk more than doubles with long-acting beta-agonist use of 3 months


A meta-analysis of 19 randomized, controlled clinical studies that lasted at least 3 months indicates that long-acting beta-agonists (LABAs) more than double the rates at which asthma patients may become hospitalized.

Related Content
© 2023 MJH Life Sciences

All rights reserved.